These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38319470)

  • 1. Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data.
    Xu Q; Chen G; Ai S; Zheng K; Zhao B; Li X
    Cardiovasc Drugs Ther; 2024 Feb; ():. PubMed ID: 38319470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data.
    Chen G; Ning LJ; Qin Y; Zhao B; Mei D; Li XM
    J Gastroenterol Hepatol; 2021 Jan; 36(1):156-162. PubMed ID: 32542684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation.
    Harel Z; McArthur E; Jeyakumar N; Sood MM; Garg AX; Silver SA; Dorian P; Blum D; Beaubien-Souligny W; Yan AT; Badve SV; Smyth B; Jun M; Jandoc R; Kitchlu A; Wald R
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1470-1479. PubMed ID: 34407990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute kidney injury following SGLT2 inhibitors among diabetic patients: a pharmacovigilance study.
    Chen G; Li X; Cui Q; Zhou Y; Zhao B; Mei D; Xuemei
    Int Urol Nephrol; 2022 Nov; 54(11):2949-2957. PubMed ID: 35579781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system.
    Orogun L; Chyou TY; Nishtala PS
    Int J Risk Saf Med; 2023; 34(2):87-99. PubMed ID: 37154187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation.
    Yao X; Tangri N; Gersh BJ; Sangaralingham LR; Shah ND; Nath KA; Noseworthy PA
    J Am Coll Cardiol; 2017 Nov; 70(21):2621-2632. PubMed ID: 29169468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal adverse effects following the use of different immune checkpoint inhibitor regimens: A real-world pharmacoepidemiology study of post-marketing surveillance data.
    Chen G; Qin Y; Fan QQ; Zhao B; Mei D; Li XM
    Cancer Med; 2020 Sep; 9(18):6576-6585. PubMed ID: 32720449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorrhage Risk Profiles among Different Antithrombotic Regimens: Evidence from a Real-World Analysis of Postmarketing Surveillance Data.
    Sun X; Ze B; Zhang LJ; BaiMa YZ; Zuo W; Zhao B; GeSang LB
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):103-112. PubMed ID: 33226545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of acute kidney injury related to small-molecule protein kinase inhibitors using the FDA adverse event reporting system.
    Fan Q; Ma J; Zhang B; Li Q; Liu F; Zhao B
    Cancer Chemother Pharmacol; 2020 Nov; 86(5):655-662. PubMed ID: 33001273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.
    Pawar A; Gagne JJ; Gopalakrishnan C; Iyer G; Tesfaye H; Brill G; Chin K; Bykov K
    JAMA; 2022 Mar; 327(11):1051-1060. PubMed ID: 35289881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocarditis following the use of different immune checkpoint inhibitor regimens: A real-world analysis of post-marketing surveillance data.
    Fan Q; Hu Y; Yang C; Zhao B
    Int Immunopharmacol; 2019 Nov; 76():105866. PubMed ID: 31491729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data.
    Dong S; Sun C
    Front Endocrinol (Lausanne); 2022; 13():1032199. PubMed ID: 36583004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome.
    Won SY; Dubinski D; Bruder M; Cattani A; Seifert V; Konczalla J
    Neurosurg Focus; 2017 Nov; 43(5):E12. PubMed ID: 29088960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation.
    Adeboyeje G; Sylwestrzak G; Barron JJ; White J; Rosenberg A; Abarca J; Crawford G; Redberg R
    J Manag Care Spec Pharm; 2017 Sep; 23(9):968-978. PubMed ID: 28854073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study.
    Piran S; Traquair H; Chan N; Robinson M; Schulman S
    J Thromb Thrombolysis; 2018 May; 45(4):557-561. PubMed ID: 29397541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney Injury Following Ibuprofen and Acetaminophen: A Real-World Analysis of Post-Marketing Surveillance Data.
    Shao QH; Yin XD; Liu HX; Zhao B; Huang JQ; Li ZL
    Front Pharmacol; 2021; 12():750108. PubMed ID: 35002695
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between oral anticoagulants and osteoporosis: Real-world data mining using a multi-methodological approach.
    Yokoyama S; Ieda S; Nagano M; Nakagawa C; Iwase M; Hosomi K; Takada M
    Int J Med Sci; 2020; 17(4):471-479. PubMed ID: 32174777
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibacterial-associated acute kidney injury among older adults: A post-marketing surveillance study using the FDA adverse events reporting system.
    Chinzowu T; Chyou TY; Nishtala PS
    Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1190-1198. PubMed ID: 35670078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.